↓ Skip to main content

Dove Medical Press

Article Metrics

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension [Erratum]

Overview of attention for article published in Clinical Ophthalmology, May 2014
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension [Erratum]
Published in
Clinical Ophthalmology, May 2014
DOI 10.2147/opth.s67403
Authors

Keiji Yoshikawa, Jun Kozaki, Hidetaka Maeda

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2014.
All research outputs
#3,095,543
of 4,506,935 outputs
Outputs from Clinical Ophthalmology
#522
of 865 outputs
Outputs of similar age
#72,739
of 106,255 outputs
Outputs of similar age from Clinical Ophthalmology
#43
of 63 outputs
Altmetric has tracked 4,506,935 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 865 research outputs from this source. They receive a mean Attention Score of 1.4. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 106,255 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.